Joaquin Mateo
@quimmateo
Physician-Scientist @VHIO #Barcelona Oncologist @vallhebron Drug Development for a more precise #prostatecancer patient care
ID:303326420
https://www.vhio.net/prostate-cancer-translational-research-group/ 22-05-2011 17:41:10
2,3K Tweets
2,1K Followers
410 Following
In the Spotlight—
Epigenetic control of cancer cell dormancy and awakening in endocrine therapy resistance, by Arnau Llinas-Bertran, Meritxell Bellet-Ezquerra, and José A. Seoane.
bit.ly/4dyLGbW
Vall d’Hebron Institute of Oncology (VHIO)
#ESMO24 : 📣Last 24 hours to submit. Watch Andres Cervantes, Rebecca Dent, Karin Jordan, Chris Verslype, Ann Partridge MD, MPH and Petros Grivas give excellent reasons to share your research. Deadline: 7 May 2024.
esmo.org/meeting-calend…
Raquel Perez-Lopez Radiomics Group Vall d’Hebron Institute of Oncology (VHIO) Becas Fundación "la Caixa" The study is also available as a medRxiv preprint -- medrxiv.org/content/10.110… -- so see you tomorrow, May 7th, Nicoll 2, 17:33. A poster summarising the work is also available in the poster hall (#0649).
Looking for an enthusiastic research fellow in nuclear medicine to develop new therapies and optimize current radioligand treatments. ☢️ Interested? Check below 👇 Institut Jules Bordet Instituut linkedin.com/posts/carlos-a…
📢New HER2DX data will be presented in ESMO Breast24.
Thanks ESMO - Eur. Oncology for the support. Looking forward to seeing you in Berlin.
Miguel Luengo-Oroz Politécnica Madrid Isabel Mendizabal CIC bioGUNE 🔴 Para finalizar la sesión 1: Perspectives from computational sciences, la Dra. Raquel Perez-Lopez del Vall d’Hebron Institute of Oncology (VHIO), nos presenta su #FlashTalk : 'Advancing Precision Oncology Through Computational Analysis of Medical Imaging'
#CRIScontraelcáncer #OtraOportunidad #DíaCienciaCRIS24
We are hiring! 👩💻👩🔬🎉
The #Radiomics group at Vall d’Hebron Institute of Oncology (VHIO) is looking for a post-doctoral researcher with experience in #AI for #MedicalImaging to join us in our current and future exciting projects
Submit your applications by emailing Raquel Perez-Lopez. The process will start immediately
Our latest paper is now out in European Urology -A prospective study of whole-body MRI in mCRPC with bone mets: the IPROMET clinical trial. Work with Raquel Perez-Lopez Radiomics Group
authors.elsevier.com/a/1ilku_6tuN-i…
My lab is hiring postdoctoral researchers. Passionate about scientific discovery? Looking to join a dynamic, diverse and welcoming team? Intrigued by genome function and stability deregulation in cancer? This may be a great opportunity for you. #CancerResearch
Our work on the origins of second malignancies in children is out in Cancer Discovery IRB Barcelona bbglab Institut de Recerca Sant Joan de Déu
doi.org/10.1158/2159-8…
1/16
Our latest paper is now out in European Urology -A prospective study of whole-body MRI in mCRPC with bone mets: the IPROMET clinical trial. Work with Raquel Perez-Lopez Radiomics Group
authors.elsevier.com/a/1ilku_6tuN-i…
congratulations and hats off to Jaleh Fallah and the FDA Oncology team for putting together these data in a single analysis. This was much needed! PCF Science
Just published! Efficacy of PARP Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: FDA Pooled Analysis - Journal of Clinical Oncology. Jaleh Fallah, Daniel Suzman.
ascopubs.org/doi/pdf/10.120…
#OCEPublications
Today we're celebrating 🎉
Marta Ligero has defended her PhD thesis and has received the highest possible grade from the committee 👩🏻💻
📣 New VHIO- CaixaResearch Scientific Seminar‼️
🔹 More is different: data integration for ovarian cancer
👩🔬 Mireia Crispin, @crispinlab Cambridge University
🗓 Friday, March 15th at 9:30
📍 Cellex Auditorium
Host: Raquel Perez-Lopez
➕ linke.to/MireiaCrispinS…
📢 It´s finally here! I´m thrilled to announce the opening of the Pediatric Cancer Epigenetics lab at #IRBBarcelona and Institut de Recerca Sant Joan de Déu! 🎉 I'm overflowing with excitement to lead groundbreaking research aimed at helping pediatric cancer patients.
#IRBScience #PCCB